Developmental Effects On Children Of Women Who Take Antiepileptic Drugs During Pregnancy
NCT00021866 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 331
Last updated 2013-11-11
Summary
The purpose of this study is to determine if antiepileptic drugs (AEDs) differ in their neurodevelopmental effects. Specifically, do the children of the women with epilepsy differ in their behavioral and cognitive development depending on which AED their mother takes during pregnancy?
Conditions
- Epilepsy
- Seizure
- Cognition Disorders
Interventions
- BEHAVIORAL
-
Differential Abilities Scale
IQ measurement at 3, 4.5 and 6 years of age
- BEHAVIORAL
-
Neuropsychological Testing
Tests of memory, attention, and behavior administered at 2,3, 4.5 and 6 Years of age
Sponsors & Collaborators
-
National Institute of Neurological Disorders and Stroke (NINDS)
collaborator NIH -
Emory University
lead OTHER
Principal Investigators
-
Kimford J. Meador, M.D. · Emory University, Atlanta
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2000-09-30
- Primary Completion
- 2010-08-31
- Completion
- 2012-08-31
Countries
- United States
- United Kingdom
Study Locations
More Related Trials
-
Phase III Double Blind Trial of Valproate Sodium for Prophylaxis of Post Traumatic Seizures
NCT00004817 ·Status: COMPLETED ·Phase: PHASE3
-
UCB Antiepileptic Drugs (AED) Pregnancy Registry (Formerly the Keppra® Pregnancy Registry)
NCT00345475 ·Status: COMPLETED
-
Application of Novel Diagnostic and Therapeutical Methods in Epilepsy and Neurodevelopmental Abnormalities in Children.
NCT03486366 ·Status: UNKNOWN ·Phase: NA
-
Study to Evaluate Phenobarbital Sodium Injection for the Treatment of Neonatal Seizures
NCT03602118 ·Status: WITHDRAWN ·Phase: PHASE3
-
Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies
NCT05364021 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Evaluate NBI-921352 as Adjunctive Therapy in Subjects With SCN8A Developmental and Epileptic Encephalopathy Syndrome (SCN8A-DEE)
NCT04873869 ·Status: TERMINATED ·Phase: PHASE2
-
Premenstrual Dysphoric Disorder and Antiepileptic Drugs
NCT00612235 ·Status: COMPLETED
-
Open Label Study of Zonisamide in the Treatment of Epilepsy in Patients With Mental Retardation
NCT00298818 ·Status: COMPLETED
-
Physiologic Effects of Topiramate on Cognition
NCT02884050 ·Status: COMPLETED ·Phase: PHASE1
-
The Benefit and Safety of Older Generation Anti-Epileptic Drugs (AEDs) in Drug-Resistant Epilepsy Children
NCT05697614 ·Status: UNKNOWN ·Phase: PHASE4
-
Medication Adherence in Individuals With Epilepsy
NCT01566500 ·Status: COMPLETED
-
Valproate Response in Aggressive Autistic Adolescents
NCT00065884 ·Status: UNKNOWN ·Phase: PHASE3
-
A Cohort Study on the Prognosis of Neonatal KCNQ2 Gene-associated Epileptic Encephalopathy
NCT03934268 ·Status: UNKNOWN
-
Evaluation and Treatment of Patients With Epilepsy
NCT00013845 ·Status: TERMINATED
-
A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE)
NCT06908226 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3
-
Pharmacokinetics of Anti-epileptic Drugs in Obese Children
NCT02993861 ·Status: COMPLETED
-
Rolandic Epilepsy Genomewide Association International Study
NCT03547050 ·Status: COMPLETED
-
Therapeutic Drug Monitoring of New Generation Antiepileptic Drugs
NCT02739282 ·Status: COMPLETED ·Phase: NA
-
Women With Epilepsy: Pregnancy Outcomes and Deliveries
NCT01259310 ·Status: COMPLETED
-
Investigating Epilepsy: Screening and Evaluation
NCT03478852 ·Status: RECRUITING
-
Lamotrigine Pregnancy Registry (LAM05)
NCT01064297 ·Status: COMPLETED
-
Pathophysiology Based Therapy of Early Onset Epileptic Encephalopathies
NCT02968966 ·Status: WITHDRAWN ·Phase: PHASE2
-
Pharmacogenetics-Based Study on Individualized Use of Sodium Valproate
NCT07046676 ·Status: RECRUITING ·Phase: PHASE4
-
Study to Evaluate the Relative Bioavailability of a New Formulation of NPT 2042 Soft-Gelatin Capsules Compared to the Original Formulation of NPT 2042
NCT07222878 ·Status: COMPLETED ·Phase: PHASE1
-
Using Next-generation Sequencing in the Diagnosis of Epilepsy and/or Intellectual Disability in a Pediatric Cohorte
NCT05193890 ·Status: COMPLETED